Abstract
Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis) and gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.
| Original language | English |
|---|---|
| Pages (from-to) | 2142-2148 |
| Number of pages | 7 |
| Journal | Journal of Biomedical Nanotechnology |
| Volume | 15 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antimicrobial photodynamic inactivation
- Copper-cysteamine nanoparticles
- Gram-negative bacteria
- Gram-positive bacteria
- Reactive oxygen species
ASJC Scopus subject areas
- Bioengineering
- Medicine (miscellaneous)
- Biomedical Engineering
- General Materials Science
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Exploration of copper-cysteamine nanoparticles as a new type of agents for antimicrobial photodynamic inactivation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver